Showing 13,781 - 13,800 results of 135,235 for search '(( 2 we decrease ) OR ( 5 ((((mean decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.94s Refine Results
  1. 13781

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  2. 13782

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  3. 13783

    Cry variables. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  4. 13784
  5. 13785
  6. 13786
  7. 13787
  8. 13788

    Treatment with anti-JAM-C antibody decreases neutrophil infiltration into the joints during antigen-induced arthritis by Gaby Palmer (636)

    Published 2011
    “…In the right panels, leukocyte infiltration per field was evaluated by semi-quantitative scoring for anti-JAM-C antibody-treated (= 6, black columns) and isotype-matched control antibody-treated (= 5, open columns) mice. There was a significant decrease in synovial neutrophil infiltration in anti-JAM-C antibody-treated mice as compared to isotype-matched antibody-treated controls. *< 0.05 versus control mice, as assessed by analysis of variance. …”
  9. 13789
  10. 13790
  11. 13791
  12. 13792
  13. 13793
  14. 13794
  15. 13795
  16. 13796

    Data_Sheet_2_LaeA Controls Virulence and Secondary Metabolism in Apple Canker Pathogen Valsa mali.docx by Yaqiong Feng (9604034)

    Published 2020
    “…In this study, we focus on LaeA, a known regulator of secondary metabolism, for its role in SMBGC regulation, toxin production, and virulence of V. mali. …”
  17. 13797
  18. 13798
  19. 13799

    DataSheet_2_Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion.pdf by Gabriel A. Aguirre (4354087)

    Published 2024
    “…We also observed that circulating concentrations of RvD5<sub>n-3 DPA</sub> levels were decreased in peripheral blood of metastatic PDAC patients when compared with those measured in plasma of non-metastatic PDAC patients. …”
  20. 13800

    Co-ablation of p53 decreases apoptosis and the survival of Dicer<sup>Δ/Δ</sup> mice. by Stephen Lyle (365801)

    Published 2014
    “…<p><b>A</b>) Hematoxylin and eosin staining of skin tissue sections of 5-month old mice. …”